In smaller transactions, ARK sold shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) and CareDx Inc (NASDAQ: CDNA ), and bought shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Veracyte Inc ...

Illumina, a next-generation DNA sequencing company, has called off its plans to buy nascent competitor Pacific Biosciences of California. Some of the banks that helped fuel the fracking boom are ...

Illumina Inc. ILMN reported first-quarter 2025 adjusted earnings per share (EPS) of 97 cents, which topped the Zacks ...